{"id":7441,"date":"2025-04-29T12:32:00","date_gmt":"2025-04-29T12:32:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/"},"modified":"2025-04-29T12:32:00","modified_gmt":"2025-04-29T12:32:00","slug":"realheart-receives-patent-approval-in-japan","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-receives-patent-approval-in-japan\/","title":{"rendered":"Realheart Receives Patent Approval in Japan"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>V\u00e4ster\u00e5s, Sweden, April 29, 2025 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval by the Japan Patent Office (JPO) concerning a pressure sensor device for artificial hearts and circulatory support systems such as Realheart\u00ae TAH. The patent is a supportive measure to ensure market protection of the company\u2019s device on the Japanese market and is valid until 2041.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Realheart develops Realheart\u00ae TAH, the world\u2019s first total artificial heart mimicking the shape, function, and blood flow pattern of the human heart. The patent (JP7656624B2) covers a pressure sensor with a biocompatible housing with integrated pressure-sensitive components used in the device. The sensor is designed to ensure accurate and safe pressure measurements in medical environments. By enabling real-time monitoring, the sensor supports automated control of artificial hearts and circulatory support systems, such as Realheart\u00ae TAH, contributes to optimized blood flow and has a potential positive effect on treatment outcomes. The design is engineered for integration into advanced medical systems, particularly within the field of artificial hearts and circulatory support.<\/p>\n<p>The granted patent confers protection for the device in Japan until 2041.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-ddde9c982a0b\">\n<p><strong class=\"mfn-heading-1\">For more information, please contact:<\/strong><br \/>Ina Laura Perkins, CEO<br \/>Phone: +46 (0) 70 406 49 21\u00a0<br \/>E-mail: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"noopener\" target=\"_blank\">inalaura.perkins@realheart.se<\/a><br \/>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, <a href=\"http:\/\/www.skmg.se\" rel=\"noopener\" target=\"_blank\">www.skmg.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-0285b54ad9f5\">\n<p><strong class=\"mfn-heading-1\">About Us<\/strong><br \/>Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. Realheart\u00ae TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trials ahead of a first clinical study in patients. The company&#039;s shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit <a href=\"http:\/\/www.realheart.se\" rel=\"noopener\" target=\"_blank\">www.realheart.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Attachments<\/strong><br \/><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/8c84d603-d9f2-4350-91b3-bf56a320a9a1\/realheart-receives-patent-approval-in-japan.pdf\" rel=\"noopener\" target=\"_blank\">Realheart Receives Patent Approval in Japan<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/8c84d603-d9f2-4350-91b3-bf56a320a9a1\/realheart-receives-patent-approval-in-japan.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/8c84d603-d9f2-4350-91b3-bf56a320a9a1\/realheart-receives-patent-approval-in-japan.pdf?type=jpg\"><\/span>Realheart Receives Patent Approval in Japan<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>V\u00e4ster\u00e5s, Sweden, April 29, 2025 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval by the Japan Patent Office (JPO) concerning a pressure sensor device for artificial hearts and circulatory support systems such as Realheart\u00ae TAH. The patent is a supportive measure to ensure market protection of&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-7441","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-ext-nq","mfn-news-tag-mfn-ext-nq-company-announcement","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart Receives Patent Approval in Japan - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart Receives Patent Approval in Japan - Realheart\" \/>\n<meta property=\"og:description\" content=\"V\u00e4ster\u00e5s, Sweden, April 29, 2025 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval by the Japan Patent Office (JPO) concerning a pressure sensor device for artificial hearts and circulatory support systems such as Realheart\u00ae TAH. The patent is a supportive measure to ensure market protection of...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-receives-patent-approval-in-japan\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-receives-patent-approval-in-japan\\\/\",\"name\":\"Realheart Receives Patent Approval in Japan - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2025-04-29T12:32:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-receives-patent-approval-in-japan\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-receives-patent-approval-in-japan\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-receives-patent-approval-in-japan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart Receives Patent Approval in Japan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart Receives Patent Approval in Japan - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart Receives Patent Approval in Japan - Realheart","og_description":"V\u00e4ster\u00e5s, Sweden, April 29, 2025 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval by the Japan Patent Office (JPO) concerning a pressure sensor device for artificial hearts and circulatory support systems such as Realheart\u00ae TAH. The patent is a supportive measure to ensure market protection of...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/","name":"Realheart Receives Patent Approval in Japan - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2025-04-29T12:32:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-receives-patent-approval-in-japan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart Receives Patent Approval in Japan"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/7441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=7441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}